S+N Logo.jpg
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
28 févr. 2024 08h00 HE | Smith & Nephew UK Ltd
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army...
S+N Logo.jpg
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
13 févr. 2024 08h00 HE | Smith & Nephew UK Ltd
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use...
S+N Logo.jpg
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting  
12 févr. 2024 15h00 HE | Smith & Nephew UK Ltd
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature*...
S+N Logo.jpg
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
12 févr. 2024 08h00 HE | Smith & Nephew UK Ltd
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the...
S+N Logo.jpg
Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report
14 janv. 2024 16h00 HE | Smith & Nephew UK Ltd
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and...
REGENETEN Patch 2024
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
11 janv. 2024 07h00 HE | Smith & Nephew UK Ltd
First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears                Smith+Nephew (LSE:SN, NYSE:SNN), the...